Complications of Bronchoscopy

Understanding the Complication Hierarchy

The American Thoracic Society notes that oxygen desaturation occurs frequently during bronchoscopy and directly correlates with the development of arrhythmias, with up to 40% of patients developing significant arrhythmias 1, 2, 3
Studies demonstrate that 40% of patients develop significant arrhythmias during bronchoscopy, with 11% experiencing major but self-limiting arrhythmias, highlighting the need for careful monitoring 1, 2
The risk of arrhythmias is particularly elevated during passage of the bronchoscope through the vocal cords, emphasizing the importance of cautious procedure technique 1, 2
Hypoxia at the end of the procedure specifically correlates with occurrence of major arrhythmias, underscoring the importance of maintaining adequate oxygenation throughout the procedure 1, 2

Significant hemorrhage during or after flexible bronchoscopy is actually uncommon, occurring in only 0.7% of routine cases, according to the British Thoracic Society 4, 1
When transbronchial biopsies are performed, significant hemorrhage (>50 ml) occurs in 1.6-4.4% of patients, as reported by the European Respiratory Society 4, 1, 5

For patients with bleeding disorders or taking anticoagulants, the American College of Chest Physicians recommends that bleeding risk remains relatively low for diagnostic bronchoscopy without biopsy, but increases substantially when biopsies are performed 4
High-risk bleeding patients include those with uraemia, immunosuppression, pulmonary hypertension, liver disease, coagulation disorders, thrombocytopenia, or patients on oral anticoagulants, as identified by the International Society for Respiratory Diseases 4, 5
Routine preoperative coagulation screening is NOT justified in patients with no risk factors, as stated by the American Thoracic Society 4, 1
In high-risk patients, checking platelet count, prothrombin time, and partial thromboplastin time before bronchoscopy is recommended by the European Respiratory Society 4, 5
If biopsy is anticipated, oral anticoagulants should be stopped at least 3 days before bronchoscopy, according to the American College of Cardiology 5
If anticoagulation must continue, INR should be reduced to <2.5, as recommended by the International Society for Thrombosis and Haemostasis 5

Severe cardiac disease is not an absolute contraindication, but these patients face the highest risk of the most common complication—arrhythmias, as noted by the American Heart Association 5
Oxygen supplementation to achieve saturation ≥90% reduces arrhythmia risk, according to the American Thoracic Society 4, 1, 5
ECG monitoring should be considered in patients with severe cardiac disease or hypoxia despite oxygen supplementation, as recommended by the European Society of Cardiology 4, 1, 5
Avoid bronchoscopy within 6 weeks of myocardial infarction due to increased arrhythmia risk, as advised by the American College of Cardiology 5

Minor blood‑tinged secretions are a common, self‑limited finding after bronchoscopy and generally require only observation and reassurance in most patients. 6
These secretions result from minor endotracheal bleeding caused by tracheal epithelial abrasions that occur during the procedure. 6

Minor bleeding is defined as blood‑streaked secretions or small amounts of blood mixed with sputum; it is typically self‑limited. 6
Massive hemorrhage (large volume of blood that obscures fibre‑optic visualization) necessitates a distinct management pathway compared with minor bleeding. 6

For patients with minor blood‑tinged secretions, routine monitoring of vital signs and oxygen saturation is recommended. 6
Providing reassurance that the bleeding is expected from mucosal trauma is an essential component of care. 6

If bleeding persists or increases, a repeat bronchoscopy should be performed to identify the source and develop an appropriate treatment plan. 6
Persistent bleeding must not be dismissed, as it may indicate a more serious underlying issue that requires bronchoscopic evaluation. 6